• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

Ter-t-butyl 5-bromo-3-methylpyridine-2-carboxylate (CAS No. 1356037-30-3): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Ter-t-butyl 5-bromo-3-methylpyridine-2-carboxylate, identified by its CAS number 1356037-30-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry due to its versatile structural features and potential applications in drug development. This compound, characterized by a pyridine core substituted with a bromo group at the 5-position, a methyl group at the 3-position, and a tert-butyl ester at the 2-position, presents a unique scaffold that can be exploited for the synthesis of various bioactive molecules.

The< strong>pyridine moiety is a cornerstone in medicinal chemistry, renowned for its ability to interact with biological targets such as enzymes and receptors. The presence of a< strong>bromo substituent at the 5-position enhances the compound's reactivity, making it a valuable precursor for further functionalization through cross-coupling reactions like Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures, which are often essential for achieving high binding affinity and selectivity in drug candidates.

The< strong>methyl group at the 3-position of the pyridine ring contributes to the overall steric and electronic properties of the molecule, influencing its solubility, metabolic stability, and interaction with biological targets. Additionally, the< strong>tert-butyl ester functionality provides a handle for further chemical manipulation, such as hydrolysis to yield a carboxylic acid or transesterification to introduce different esters. These transformations are crucial in optimizing drug-like properties, including pharmacokinetic profiles and oral bioavailability.

In recent years, there has been a surge in research focused on developing novel therapeutic agents targeting neurological disorders. Pyridine derivatives have shown promise in this area due to their ability to modulate neurotransmitter systems. For instance, compounds with structural similarities to< strong>tert-butyl 5-bromo-3-methylpyridine-2-carboxylate have been investigated for their potential as acetylcholinesterase inhibitors, which are critical in managing cognitive decline associated with Alzheimer's disease. The< strong>bromo substituent facilitates further derivatization into more complex structures that can exhibit enhanced inhibitory activity against this enzyme.

The pharmaceutical industry has also explored< strong>tert-butyl 5-bromo-3-methylpyridine-2-carboxylate as a building block for antiviral and anticancer agents. The pyridine scaffold is frequently found in nucleoside analogs and kinase inhibitors, which are key components in modern antiviral therapies. The bromo group enables palladium-catalyzed cross-coupling reactions, allowing for the introduction of aryl or heteroaryl groups that can improve binding interactions with viral proteases or kinases. Similarly, in oncology research, pyridine derivatives have been designed to target specific mutations or overactive signaling pathways in cancer cells.

The synthesis of< strong>tert-butyl 5-bromo-3-methylpyridine-2-carboxylate involves multi-step organic transformations that highlight its synthetic utility. Starting from commercially available precursors such as bromopyridines and ketones, the compound can be synthesized through Vilsmeier-Haack formylation followed by bromination and esterification. This synthetic route underscores the compound's role as a versatile intermediate that can be tailored to meet specific structural requirements.

In conclusion, tert-butyl 5-bromo-3-methylpyridine-2-carboxylate (CAS No. 1356037-30-3) represents an important chemical entity in pharmaceutical research. Its unique structural features make it an excellent candidate for further derivatization into novel bioactive molecules targeting various diseases. The ongoing exploration of its applications in drug development underscores its significance as a key intermediate in modern medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)